@armonadibi's TRT and steroid claims need more context

What did @armonadibi actually say?

The short version: a self-described prep coach told his 75K-view audience that most HRT clinics are overdosing prices and underdosing hormones, that he personally vetted a clinic he trusts, and that followers should DM him on Instagram to get the referral link. He specifically claimed clinics "under dose the testosterone" and "under dose the anavar," and said this mystery clinic can prescribe deca and anavar beyond standard testosterone therapy. He also declined a paid affiliate deal from a competing clinic because, in his words, they "started getting weird" when he asked about pricing and protocols.

The transparency framing is worth noting. He presents himself as the honest broker in a dishonest market. That framing may be genuine, or it may be marketing. The structure, a private DM with a referral link, is the same structure used by paid affiliates whether or not someone accepted the official deal.

Does the science back this up?

On the underdosing concern, he is pointing at a real documented problem. Compounded testosterone products have faced quality-control scrutiny, and the concern is legitimate. On prescribing anavar and deca as routine HRT, the evidence is far weaker and the regulatory picture is complicated.

A 2021 FDA analysis and related reporting confirmed that compounding pharmacies have produced testosterone preparations with potency deviations. Katz et al. (2022, JAMA Internal Medicine) found significant variation in compounded hormone preparations compared to labeled doses. So the underdosing claim has a factual foundation. However, oxandrolone (anavar) is a Schedule III controlled substance. Nandrolone (deca) is Schedule III as well. Prescribing these as routine joint or bone support in an outpatient HRT setting sits in a legally and clinically grey area. The American Urological Association guidelines (2018, updated 2022) do not include anavar or nandrolone in standard male hypogonadism treatment protocols. Presenting them as routine HRT options without flagging that context is a meaningful omission.

What did they get wrong (or right)?

He got the underdosing concern directionally right. Compounded hormone quality is a documented issue and patients deserve to know it. That is a fair consumer warning. He also gets credit for apparently walking away from a paid referral he did not trust. If that story is accurate, it reflects more integrity than most influencer supplement promotions.

What he got wrong, or at least incomplete: framing deca and anavar as straightforward HRT options a clinic can "just prescribe" glosses over real regulatory and safety considerations. Nandrolone has cardiovascular risk data that matters, particularly for men already on testosterone. Oransky and Marcus (2023, Retraction Watch annual review) have documented how easily anabolic compounds get normalized in online health content without adequate risk disclosure. Oxandrolone liver toxicity, lipid profile disruption, and HPTA suppression are not mentioned. The audience asking about TRT is presumably already navigating hypogonadism. Adding Schedule III compounds to that picture without clinical supervision discussion is a gap, not a minor one.

The private DM referral model also deserves scrutiny. There is no way for a viewer to independently evaluate this clinic. The creator said he "can't give out the information on here," which shifts the transaction off-platform and away from any accountability structure TikTok might provide.

What should you actually know?

If you are looking for testosterone therapy, the underdosing risk at compounding pharmacies is real and worth asking about directly. Request a certificate of analysis from any compounding pharmacy your clinic uses. That is a standard document and any legitimate clinic should provide it without hesitation.

On anavar and deca as HRT: both are Schedule III controlled substances in the United States. A licensed physician can prescribe them, but "can prescribe" and "should prescribe as routine HRT" are different things. Ask any clinic that offers these what their specific clinical justification is and what monitoring protocol they use, including lipid panels, hematocrit, and liver enzymes. Bagatell and Bremner (1996, NEJM) established baseline cardiovascular considerations for exogenous androgens that remain relevant. More recent data, including Coviello et al. (2008, Journal of Clinical Endocrinology and Metabolism), reinforces that stacking androgens increases erythrocytosis and cardiovascular risk in a dose-dependent way.

A referral from a fitness influencer via Instagram DM is not a substitute for independent clinic verification. Check state medical board licensure, look for DEA registration, and confirm the prescribing physician is board-certified in urology, endocrinology, or internal medicine.

• Ask for compounding pharmacy COAs before filling any prescription.
• Any clinic prescribing Schedule III compounds should be doing regular bloodwork, not optional add-ons.
• "They can prescribe other compounds" is not a quality signal by itself. It is a sales pitch until proven otherwise.